metoclopramide has been researched along with captopril in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (42.11) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (31.58) | 29.6817 |
| 2010's | 5 (26.32) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Anderson, PW; Hsueh, WA; Kletsky, OA; Malarkey, WB; Salk, J | 1 |
| Chandler, W; Eggena, P; Stern, N; Tuck, ML | 1 |
| Andonova, K; Koev, D; Moskov, M; Tcharaktchiev, D; Zachariéva, S | 1 |
| Mazzocchi, G; Nussdorfer, GG; Rebuffat, P; Robba, C | 1 |
| Belloni, AS; Gottardo, G; Mazzocchi, G; Meneghelli, V; Nussdorfer, GG; Rebuffat, P; Robba, C; Stachowiak, A | 1 |
| Althoff, PH; Bussmann, WD; Fassbinder, W; Hadler, D; Jungmann, E; Kaltenbach, M; Schöffling, K; Störger, H | 1 |
| Weinberger, MH | 1 |
| Barrett, J; Golub, MS; Sambhi, MP; Sowers, JR; Tuck, ML | 1 |
1 review(s) available for metoclopramide and captopril
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for metoclopramide and captopril
| Article | Year |
|---|---|
Aldosterone and prolactin responsiveness after prolonged treatment of congestive heart failure with captopril.
Topics: Adult; Aged; Aldosterone; Captopril; Dexamethasone; Electrolytes; Epinephrine; Female; Heart Failure; Humans; Hydrocortisone; Male; Metoclopramide; Middle Aged; Norepinephrine; Prolactin; Proline; Renin; Time Factors | 1985 |
17 other study(ies) available for metoclopramide and captopril
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
The effect of angiotensin-converting enzyme inhibition on prolactin responses in normal and hyperprolactinemic subjects.
Topics: Adult; Angiotensin II; Blood Pressure; Captopril; Diet; Diet, Sodium-Restricted; Female; Humans; Hyperprolactinemia; Male; Metoclopramide; Prolactin; Reference Values; Renin; Sodium; Thyrotropin-Releasing Hormone | 1989 |
Effects of central and peripheral dopamine antagonism on aldosterone secretion: evidence for adrenal mechanism.
Topics: Adrenal Cortex; Aldosterone; Animals; Captopril; Cerebral Ventricles; Dexamethasone; Domperidone; Dopamine Antagonists; Injections, Intraventricular; Levodopa; Male; Metoclopramide; Rats; Rats, Inbred Strains; Renin | 1989 |
[Effect of captopril on the plasma aldosterone response to metoclopramide in normal subjects].
Topics: Adult; Aldosterone; Captopril; Female; Humans; Male; Metoclopramide; Prolactin; Reference Values; Renin | 1989 |
Long-term trophic effect of sodium restriction on the rat adrenal zona glomerulosa. II. The possible involvement of the inhibition of the dopaminergic system.
Topics: Adrenal Glands; Aldosterone; Angiotensin II; Animals; Bromocriptine; Captopril; Diet, Sodium-Restricted; Dopamine; Endoplasmic Reticulum; Hypertrophy; Metoclopramide; Mitochondria; Potassium; Rats; Rats, Inbred Strains; Sodium | 1988 |
Investigations on the possible involvement of the dopaminergic system in the modulation of the growth and steroidogenic capacity of the rat adrenal zona glomerulosa: a coupled morphometric and biochemical study.
Topics: Adrenal Cortex; Aldosterone; Angiotensin II; Animals; Bromocriptine; Captopril; Male; Metoclopramide; Rats; Rats, Inbred Strains; Receptors, Dopamine; Renin; Sodium | 1987 |
Primary aldosteronism: diagnosis and differentiation of subtypes.
Topics: Captopril; Diagnosis, Differential; Humans; Hyperaldosteronism; Metoclopramide; Renin-Angiotensin System; Sodium Chloride | 1984 |
Dopaminergic control of aldosterone secretion is independent of the renin-angiotensin system in rats.
Topics: Aldosterone; Animals; Captopril; Dopamine; Levodopa; Male; Metoclopramide; Nephrectomy; Rats; Renin; Saralasin; Stimulation, Chemical; Time Factors | 1980 |